Ancistrolikokines E–H and related 5,8′-coupled naphthylisoquinoline alkaloids from the Congolese lianaAncistrocladus likokowith antiausterity activities against PANC-1 human pancreatic cancer cells

RSC Advances
2017.0

Abstract

A striking feature of the metabolite profile of Ancistrocladus likoko (Ancistrocladaceae) is the exclusive production of 5,8'-linked naphthylisoquinoline alkaloids varying in their OMe/OH substitution patterns and in the hydrogenation degree in their isoquinoline portions. Here we present nine new compounds of this coupling type isolated from the twigs of this remarkable Central African liana. Three of them, the ancistrolikokines E (9), E-2 (10), and F (11), are the first 5,8'-linked naphthyldihydroisoquinolines found in nature with R-configuration at C-3. The fourth new metabolite, ancistrolikokine G (12), is so far the only representative of the 5,8'-coupling type that belongs to the very rare group of alkaloids with a fully dehydrogenated isoquinoline portion. Moreover, five new N-methylated naphthyltetrahydroisoquinolines, named ancistrolikokines A(2) (13), A(3) (14), C-2 (5), H (15), and H-2 (16) are presented, along with six known 5,8'-linked alkaloids, previously identified in related African Ancistrocladus species, now found for the first time in A. likoko. The structural elucidation was achieved by spectroscopic analysis (HRESIMS, 1D and 2D NMR) and by chemical (oxidative degradation) and chiroptical (electronic circular dichroism) methods. The new ancistrolikokines showed moderate to good preferential cytotoxic activities towards pancreatic PANC-1 cells in nutrient-deprived medium (NDM), without causing toxicity under normal, nutrient-rich conditions, with ancistrolikokine H-2 (16) being the most potent compound.

Knowledge Graph

Similar Paper

Ancistrolikokines E–H and related 5,8′-coupled naphthylisoquinoline alkaloids from the Congolese lianaAncistrocladus likokowith antiausterity activities against PANC-1 human pancreatic cancer cells
RSC Advances 2017.0
Ancistrolikokine I and further 5,8′-coupled naphthylisoquinoline alkaloids from the Congolese liana Ancistrocladus likoko and their cytotoxic activities against drug-sensitive and multidrug resistant human leukemia cells
Fitoterapia 2018.0
Ancistroyafungines A-D, 5,8′- and 5,1′-coupled naphthylisoquinoline alkaloids from a Congolese Ancistrocladus species, with antiausterity activities against human PANC-1 pancreatic cancer cells
Fitoterapia 2018.0
Ancistrolikokines A−C:  New 5,8‘-Coupled Naphthylisoquinoline Alkaloids from <i>Ancistrocladus</i> <i>likoko</i>
Journal of Natural Products 2000.0
Ancistrolikokines A−C:  New 5,8‘-Coupled Naphthylisoquinoline Alkaloids from <i>Ancistrocladus</i> <i>likoko</i>
Journal of Natural Products 2000.0
Michellamines A<sub>6</sub> and A<sub>7</sub>, and further mono- and dimeric naphthylisoquinoline alkaloids from a Congolese Ancistrocladus liana and their antiausterity activities against pancreatic cancer cells
RSC Advances 2018.0
Ancistrolikokine D, a 5,8′-coupled naphthylisoquinoline alkaloid, and related natural products from Ancistrocladus likoko
Phytochemistry 2003.0
Ancistrolikokine D, a 5,8′-coupled naphthylisoquinoline alkaloid, and related natural products from Ancistrocladus likoko
Phytochemistry 2003.0
Ealamines A–H, a Series of Naphthylisoquinolines with the Rare 7,8′-Coupling Site, from the Congolese Liana <i>Ancistrocladus ealaensis</i>, Targeting Pancreatic Cancer Cells
Journal of Natural Products 2019.0
Ancistrobrevines E-J and related naphthylisoquinoline alkaloids from the West African liana Ancistrocladus abbreviatus with inhibitory activities against Plasmodium falciparum and PANC-1 human pancreatic cancer cells
Fitoterapia 2018.0